If you enjoy this content, please share it with a colleague
Varian Medical Systems
RELATED CONTENT
IMRIS Inc. and Varian Medical Systems announced that data presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality magnetic resonance (MR) images at each treatment session.
Varian Medical Systems and Siemens Healthcare showcased a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO).
The variety of radiation therapy options continues to grow with the development of treatment planning software, imaging systems for guidance, linear accelerators and more. The external-beam radiation therapy (EBRT) market includes many different types of treatment, from traditional whole-body irradiation (WBI) to conformal radiation therapy (3-D CRT) and intensity-modulated radiation therapy (IMRT). Despite a major decline in 2009, the U.S. radiation therapy market is bouncing back, according to a study published in July by IMV Medical Information Division.[1] Improvements in technologies are helping to drive activity as clinics and hospitals implement advanced techniques to more accurately target and treat cancers.
Beatriz Amendola, M.D., FACR, FASTRO, radiation oncologist, medical director, Innovative Cancer Institute (ICI), decided to work in solo practice in 1999 after moving from Philadelphia to Miami. In Miami, she found there were no privately owned, freestanding facilities offering radiology oncology services to patients. All services were either rendered through a hospital or through a university. That is when Amendola decided to start her own practice, founding the Brachytherapy Center of South Florida in 2002, which is mostly dedicated to the management of early breast cancer and skin cancer using brachytherapy.
In the past 20 years there have been considerable improvements in the treatment of prostate cancer. As it is across all radiation oncology, techniques have evolved from conventional external beam radiation therapy (EBRT), to more targeted therapies that are delivered in fewer visits. One of the latest notable trends in radiotherapy is the emergence of real-time image guidance for intensity-modulated radiation therapy (IMRT). For prostate cancer, radiotherapy is often deployed in conjunction with surgery (prostatectomy) or as curative therapy, depending on the stage of disease. As these new techniques emerge, it becomes more important for clinicians to identify which ones work most effectively and for which patients.
July 16, 2013 — The U.S. radiation therapy market appears to be rebounding after a major decline in 2009, with radiation oncology centers budgeting more money for capital equipment purchases this year compared to four years ago, according to a new study published by IMV Medical Information Division.
This is a brief overview of the newest software systems available on the treatment planning systems market.
With the sheer volume of patient information growing by the minute in the healthcare industry, it is important for providers to have an information system that not only captures and maintains data, but also performs its functions effectively and meaningfully. As the electronic health record (EHR) requirements for Stage 2 meaningful use (MU) continue to bear down on clinicians, vendors — especially in the field of oncology — will need to tweak and adjust to ensure their systems fulfill the needs of providers.
Varian Medical Systems received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian’s diagnostic X-ray image processing workstation that combines radiographic/fluoroscopy (RF) and digital radiography (DR) capabilities on one platform. Varian’s Nexus DRF Digital X-Ray Imaging System has the ability to interface with a variety of image receptors, including CCD cameras and commercially available flat-panel image detectors.
Varian Medical Systems and Paul Scherrer Institute (PSI) announced a collaboration to further advance motion management techniques for proton therapy. The multi-year agreement, aimed at optimizing treatment strategies for indications such as cancer in the lung, liver, pancreas and breast, will evaluate strategies using a 4-D treatment planning simulator developed by PSI.